Douglass Winthrop Advisors, LLC - Novozymes A/S ownership

Novozymes A/S's ticker is NVZMY and the CUSIP is 670108109. A total of 15 filers reported holding Novozymes A/S in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Douglass Winthrop Advisors, LLC ownership history of Novozymes A/S
ValueSharesWeighting
Q4 2020$1,655,000
+48.2%
28,995
+63.4%
0.05%
+30.6%
Q3 2020$1,117,000
+42.8%
17,746
+31.3%
0.04%
+24.1%
Q2 2020$782,000
+49.5%
13,520
+17.6%
0.03%
+26.1%
Q1 2020$523,000
-2.8%
11,497
+4.4%
0.02%
+21.1%
Q4 2019$538,000
+58.7%
11,013
+36.6%
0.02%
+46.2%
Q3 2019$339,000
+5.6%
8,063
+16.8%
0.01%0.0%
Q2 2019$321,000
-1.2%
6,902
-2.4%
0.01%
-7.1%
Q1 2019$325,000
+0.9%
7,069
-1.6%
0.01%
-12.5%
Q4 2018$322,000
+58.6%
7,185
+93.8%
0.02%
+77.8%
Q3 2018$203,0003,7070.01%
Other shareholders
Novozymes A/S shareholders Q2 2020
NameSharesValueWeighting ↓
Lenox Wealth Management, Inc. 62,488$2,907,0000.87%
ZEVIN ASSET MANAGEMENT LLC 34,899$1,624,0000.52%
HIGH POINTE CAPITAL MANAGEMENT LLC 5,090$238,0000.33%
BOSTON FINANCIAL MANGEMENT LLC 108,846$5,065,0000.29%
Moloney Securities Asset Management, LLC 15,263$713,0000.24%
Boston Common Asset Management, LLC 24,577$1,148,0000.14%
Hemenway Trust Co LLC 12,125$564,0000.09%
Renaissance Investment Group LLC 5,000$234,0000.09%
QUADRANT CAPITAL GROUP LLC 5,748$263,0000.04%
Douglass Winthrop Advisors, LLC 6,902$321,0000.01%
View complete list of Novozymes A/S shareholders